Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | URGN | RANI | SLDB | ||
| Company | Urogen Pharma Ltd | Rani Therapeutics Holdings Inc Cl A | Solid Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 13.97 | 6.48 | 8.52 | ||
| High | 14.32 | 6.70 | 9.08 | ||
| Low | 13.69 | 6.29 | 8.41 | ||
| Last | 14.15 | 6.68 | 8.98 | ||
| Change | +0.33 | +0.12 | +0.44 | ||
| % Change | +2.39% | +1.83% | +5.15% | ||
| Volume | 135,619 | 42,057 | 189,872 | ||
| 20-Day Average Volume | 300,161 | 241,613 | 189,829 | ||
| Previous Close | 13.82 | 6.56 | 8.54 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.00 | 5.30 | 10.46 | ||
| 20-Day Raw Stochastic | 56.87% | 63.72% | 18.66% | ||
| 20-Day Relative Strength | 45.72% | 63.63% | 41.04% | ||
| Weighted Alpha | -35.52 | +38.12 | -4.56 | ||
| Today's Opinion | 24% Sell | 100% Buy | 40% Buy | ||
| Previous Opinion | 40% Sell | 100% Buy | 24% Buy | ||
| Last Month's Opinion | 8% Buy | 8% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.06% since 04/19/24 | -5.52% since 04/19/24 | +3.22% since 04/19/24 | ||
| Low | 13.58 on 04/22/24 | 6.24 on 04/25/24 | 7.95 on 04/25/24 | ||
| High | 14.85 on 04/23/24 | 7.65 on 04/22/24 | 9.61 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -6.72% since 03/26/24 | +110.06% since 03/26/24 | -33.82% since 03/26/24 | ||
| Low | 12.37 on 04/11/24 | 2.97 on 03/27/24 | 7.95 on 04/25/24 | ||
| High | 15.67 on 03/27/24 | 8.75 on 04/17/24 | 15.05 on 03/28/24 | ||
| 3-Month | |||||
| %Chg | -11.95% since 01/26/24 | +86.59% since 01/26/24 | +12.53% since 01/26/24 | ||
| Low | 12.37 on 04/11/24 | 2.85 on 03/26/24 | 5.40 on 02/01/24 | ||
| High | 19.87 on 02/16/24 | 8.75 on 04/17/24 | 15.05 on 03/28/24 | ||
| 6-Month | |||||
| %Chg | +26.57% since 10/26/23 | +235.68% since 10/26/23 | +349.00% since 10/26/23 | ||
| Low | 10.63 on 10/30/23 | 1.82 on 11/02/23 | 1.81 on 10/30/23 | ||
| High | 19.87 on 02/16/24 | 8.75 on 04/17/24 | 15.05 on 03/28/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 324,134 | 329,030 | 323,102 | ||
| Shares Outstanding, K | 23,454 | 50,157 | 37,834 | ||
| Annual Sales | 82,710,000 | 0 | 0 | ||
| Annual Net Income | -102,240,000 | -33,970,000 | -96,020,000 | ||
| Last Quarter Sales | 23,530,000 | 0 | 0 | ||
| Last Quarter Net Income | -26,020,000 | -7,100,000 | -20,340,000 | ||
| 60-Month Beta | 1.07 | 0.92 | 1.93 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.72 on 03/14/24 | -0.27 on 03/20/24 | -1.00 on 03/13/24 | ||
| Latest Earnings Date | 05/09/24 | 05/08/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||